Table 2.
Correlation of antiBP180 and antiBP230 antibody titer with clinical features of bullous pemphigoid (n=30)
| Clinical features | BPAg180 | BPAg230 | ||
|---|---|---|---|---|
|
|
|
|||
| r | P | r | P | |
| Pruritus | 0.286 | 0.126 | 0.250 | 0.183 |
| Excoriations | 0.018 | 0.923 | -0.157 | 0.407 |
| Spontaneous healing of erosions | 0.199 | 0.293 | 0.174 | 0.359 |
| Urticarial plaque | 0.262 | 0.161 | -0.117 | 0.539 |
| Erythematous patch | 0.259 | 0.167 | 0.157 | 0.407 |
| Eczematous plaque | -0.033 | 0.861 | -0.301 | 0.106 |
| Milia | -0.134 | 0.481 | 0.134 | 0.481 |
| Perifollicular pigmentation | 0.396 | 0.031 | 0.009 | 0.962 |
| Dyspigmentation | 0.026 | 0.891 | -0.223 | 0.237 |
| Fresh episode | -0.111 | 0.560 | -0.040 | 0.833 |
| Generalized disease | 0.199 | 0.293 | 0.174 | 0.359 |
| Hemorrhagic fluid | 0.301 | 0.106 | -0.134 | 0.481 |
| Purulent fluid | 0.174 | 0.359 | -0.174 | 0.359 |
| Mucosal involvement | 0.205 | 0.276 | 0.063 | 0.743 |